Inhibition of cholesterol biosynthesis overcomes enzalutamide resistance in castration-resistant prostate cancer (CRPC).

Abstract

Enzalutamide, a nonsteroidal second-generation antiandrogen, has been recently approved for the management of castration-resistant prostate cancer (CRPC). Although patients can benefit from enzalutamide at the beginning of this therapy, acquired enzalutamide resistance usually occurs within a short period. This motivated us to investigate the mechanism involved and possible approaches for overcoming enzalutamide resistance in CRPC. In the present study, we found that 3-hydroxy-3-methyl-glutaryl-CoA reductase (HMGCR), a crucial enzyme in the mevalonate pathway for sterol biosynthesis, is elevated in enzalutamide-resistant prostate cancer cell lines. HMGCR knockdown could resensitize these cells to the drug, and HMGCR overexpression conferred resistance to it, suggesting that aberrant HMGCR expression is an important enzalutamide-resistance mechanism in prostate cancer cells. Furthermore, enzalutamide-resistant prostate cancer cells were more sensitive to statins, which are HMGCR inhibitors. Of note, a combination of simvastatin and enzalutamide significantly inhibited the growth of enzalutamide-resistant prostate cancer cells in vitro and tumors in vivo Mechanistically, simvastatin decreased protein levels of the androgen receptor (AR), which was further reduced in combination with enzalutamide. We observed that the decrease in AR may occur through simvastatin-mediated inhibition of the mTOR pathway, whose activation was associated with increased HMGCR and AR expression. These results indicate that simvastatin enhances the efficacy of enzalutamide-based therapy, highlighting the therapeutic potential of statins to overcome enzalutamide resistance in CRPC.

• Authors: Yifan Kong, Lijun Cheng, Fengyi Mao, Zhuangzhuang Zhang, Yanquan Zhang, Elia Farah, Jacob Bosler, Yunfeng Bai, Nihal Ahmad, Shihuan Kuang, Lang Li, Xiaoqi Liu
• Journal: The Journal of biological chemistry (J Biol Chem) Vol. 293 Issue 37 Pg. 14328-14341 (09 14 2018) ISSN: 1083-351X [Electronic] United States
• PMID: 30089652 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
• Copyright: © 2018 Kong et al.

Chemical References

• Benzamides
• Nitriles
• Receptors, Androgen
• Phenylthiohydantoin
• enzalutamide
• Cholesterol
• Hydroxymethylglutaryl CoA Reductases

Topics

• Animals
• Benzamides
• Cell Line, Tumor
• Cholesterol (biosynthesis)
• Drug Resistance, Neoplasm
• Humans
• Hydroxymethylglutaryl CoA Reductases (genetics, metabolism)
• Male
• Mice
• Mice, Nude
• Nitriles
• Phenylthiohydantoin (administration & dosage, analogs & derivatives)
• Prostatic Neoplasms, Castration-Resistant (drug therapy, enzymology, genetics, metabolism)
• Receptors, Androgen (genetics, metabolism)